Medical Science Liaison / Senior Medical Science Liaison (Central) – Rare Disease
Zevra Therapeutics
This listing was originally posted on Zevra Therapeutics's careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Upgrade to Pro to access the AI-generated 'Read before applying' briefing and other premium pharma intelligence.
Upgrade to Pro — $25/moAbout the role
Zevra Therapeutics is seeking a Medical Science Liaison (MSL) or Senior Medical Science Liaison (Senior MSL) to join our U.S. Medical Affairs organization and support the Central U.S. territory.
The Senior MSL will serve as a field-based scientific and clinical expert, developing trusted relationships with healthcare professionals (HCPs), key opinion leaders (KOLs), researchers, and other healthcare decision-makers. Through high-quality scientific exchange and collaboration, the Senior MSL will advance understanding of rare diseases and Zevra's therapeutic portfolio, support evidence generation and clinical initiatives, and provide meaningful insights that help inform medical and clinical strategy.
The successful candidate will bring deep scientific expertise, strong business acumen, intellectual curiosity, and the ability to translate complex clinical information into meaningful scientific dialogue. They will maintain comprehensive knowledge of relevant disease states, Zevra's therapeutic portfolio, emerging science, the competitive landscape, and applicable regulatory and compliance requirements while ensuring all scientific exchange is accurate, balanced, and evidence-based.
This role is well suited for an experienced MSL who is passionate about rare diseases, enjoys building meaningful relationships within the medical and scientific community, and thrives in a collaborative, growing organization focused on improving outcomes for patients with significant unmet needs.
Territory: Central U.S. – Illinois, Ohio, Indiana, Michigan, Minnesota, Wisconsin, Kentucky, Iowa, Nebraska, North Dakota, South Dakota, and Kansas
What you'll do
Qualifications
Equal Employment Opportunity Statement
Zevra is an equal opportunity employer that is committed to diversity and inclusion in the workplace. We prohibit discrimination and harassment of any kind based on race, color, sex, religion, sexual orientation, national origin, disability, genetic information, pregnancy, or any other protected characteristic as outlined by federal, state, or local laws.
Notice to External Recruiters
Zevra does not accept unsolicited resumes from agencies or search firms. Recruiters are requested not to contact employees or hiring managers. All candidate submissions must be coordinated through our Human Resources team and require a prior written agreement. Any resumes sent without such an agreement will not create any implied obligation.
About Zevra Therapeutics, Inc.
We are a rare disease therapeutics company leading with science to make life-changing therapeutics available to patients with significant unmet needs. We involve key thought leaders, physicians, patients, care partners, and advocacy groups in all of our clinical and regulatory development strategies.
With a keen understanding that drug development often requires creative solutions, we have the insight and expertise to forge new pathways to success that others have missed. By following the data without bias, our transparent narratives and common-sense perspective have successfully overcome complex development challenges to make much-needed therapies available to patients.
Nimble and dauntless, we push boundaries beyond what is thought to be possible and advance new therapies that have the potential to bring meaningful improvement to patients’ lives.
Explore related positions you might be interested in
We'll notify you when matching roles are posted.
Interviewed at Zevra Therapeutics?
Help others prepare — share your experience anonymously.
BIOTECHNOLOGY
Modifications of Existing Drugs
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo